181 related articles for article (PubMed ID: 31217513)
1. MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature.
Gendoo DMA; Zon M; Sandhu V; Manem VSK; Ratanasirigulchai N; Chen GM; Waldron L; Haibe-Kains B
Sci Rep; 2019 Jun; 9(1):8770. PubMed ID: 31217513
[TBL] [Abstract][Full Text] [Related]
2. Essential gene profiles in breast, pancreatic, and ovarian cancer cells.
Marcotte R; Brown KR; Suarez F; Sayad A; Karamboulas K; Krzyzanowski PM; Sircoulomb F; Medrano M; Fedyshyn Y; Koh JLY; van Dyk D; Fedyshyn B; Luhova M; Brito GC; Vizeacoumar FJ; Vizeacoumar FS; Datti A; Kasimer D; Buzina A; Mero P; Misquitta C; Normand J; Haider M; Ketela T; Wrana JL; Rottapel R; Neel BG; Moffat J
Cancer Discov; 2012 Feb; 2(2):172-189. PubMed ID: 22585861
[TBL] [Abstract][Full Text] [Related]
3. Pathway-based classification of cancer subtypes.
Kim S; Kon M; DeLisi C
Biol Direct; 2012 Jul; 7():21. PubMed ID: 22759382
[TBL] [Abstract][Full Text] [Related]
4. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
5. curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome.
Ganzfried BF; Riester M; Haibe-Kains B; Risch T; Tyekucheva S; Jazic I; Wang XV; Ahmadifar M; Birrer MJ; Parmigiani G; Huttenhower C; Waldron L
Database (Oxford); 2013; 2013():bat013. PubMed ID: 23550061
[TBL] [Abstract][Full Text] [Related]
6. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
Liu D
Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
An Y; Yang Q
Biomed Res Int; 2020; 2020():7594098. PubMed ID: 33381581
[TBL] [Abstract][Full Text] [Related]
8. Stromal responses among common carcinomas correlated with clinicopathologic features.
Chen JL; Espinosa I; Lin AY; Liao OY; van de Rijn M; West RB
Clin Cancer Res; 2013 Sep; 19(18):5127-35. PubMed ID: 23804424
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer survival analysis defines a signature that predicts outcome.
Raman P; Maddipati R; Lim KH; Tozeren A
PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers.
Ayyildiz D; Gov E; Sinha R; Arga KY
OMICS; 2017 May; 21(5):285-294. PubMed ID: 28375712
[TBL] [Abstract][Full Text] [Related]
11. Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets.
Yao J; Zhao Q; Yuan Y; Zhang L; Liu X; Yung WK; Weinstein JN
PLoS One; 2012; 7(9):e45894. PubMed ID: 23029298
[TBL] [Abstract][Full Text] [Related]
12. Novel gene signatures for prognosis prediction in ovarian cancer.
Bao M; Zhang L; Hu Y
J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
[TBL] [Abstract][Full Text] [Related]
13. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
14. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
Madden SF; Clarke C; Gaule P; Aherne ST; O'Donovan N; Clynes M; Crown J; Gallagher WM
Breast Cancer Res; 2013; 15(4):R52. PubMed ID: 23820017
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an immune gene-set based Prognostic signature in ovarian cancer.
Shen S; Wang G; Zhang R; Zhao Y; Yu H; Wei Y; Chen F
EBioMedicine; 2019 Feb; 40():318-326. PubMed ID: 30594555
[TBL] [Abstract][Full Text] [Related]
16. A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis.
Yin X; Wang X; Shen B; Jing Y; Li Q; Cai MC; Gu Z; Yang Q; Zhang Z; Liu J; Li H; Di W; Zhuang G
Sci Rep; 2016 Aug; 6():31079. PubMed ID: 27498762
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer.
Zou W; Li L; Wang Z; Jiang N; Wang F; Hu M; Liu R
Bioengineered; 2021 Dec; 12(1):9006-9020. PubMed ID: 34654352
[TBL] [Abstract][Full Text] [Related]
18. Extracting Pathway-level Signatures from Proteogenomic Data in Breast Cancer Using Independent Component Analysis.
Liu W; Payne SH; Ma S; Fenyö D
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S169-S182. PubMed ID: 31213479
[TBL] [Abstract][Full Text] [Related]
19. Co-expressed functional module-related genes in ovarian cancer stem cells represent novel prognostic biomarkers in ovarian cancer.
Gov E
Syst Biol Reprod Med; 2020 Aug; 66(4):255-266. PubMed ID: 32441533
[TBL] [Abstract][Full Text] [Related]
20. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence.
Pawar S; Liew TO; Stanam A; Lahiri C
Chem Biol Drug Des; 2020 Sep; 96(3):995-1004. PubMed ID: 32410355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
